Skip to contentM
MAIA Biotechnology, Inc.
M
MAIAMAIA Biotechnology, Inc. Released Nov 9, 2022, after the close
10-Q filed Nov 9, 2022, 40 days after period end · 0000950170-22-023956
Q3 2022 · 10-Q
Revenue$0.00$0.00derivedno prior Q3 2021 on fileno prior Q2 2022 on file Net Income-$4.90M-$4.90M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MAIA Biotechnology, Inc. · CIK 1878313 · Engraved from SEC EDGAR
N/M vs Q2 2022
EPS Diluted-$0.48-$0.48N/M vs Q3 2021N/M vs Q2 2022 Operating Income-$5,095,586N/M Operating Cash Flowderived-$4,319,159N/M ended Sep 30, 2022 · filed Nov 9, 2022 · 40 d after period end